Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-014063)

Filing Details

Accession Number:: 0001179110-18-014063
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-18 16:36:20
Reporting Period:: 2018-12-10

Accepted Time:: 2018-12-18 16:36:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113481	Medicines Co	MDCO	Pharmaceutical Preparations (2834)	043324394

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761799	Mark Timney	8 Sylvan Way Parsippany NJ 07054	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-17	26,863	$18.60	26,863	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Acquisiton	2018-12-10	450,000	$0.00	450,000	$20.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
450,000		2028-12-10	No	4	A	Direct

Footnotes

Represents the weighted average purchase price of the shares purchased ranging from a low of $17.87 to a high of $19.17 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
This option vests 25% on December 10, 2019 and in thirty-six equal monthly installments thereafter.